Hosts of Beyond the Journal, Jack West & Charu Aggarwal, asked me to come on their podcast to chat about the balance of medical talent between academia & industry, as well as the advantages of different social media platforms for thoughtful discussion. (45:04)
I read this book “When Blood Breaks Down” written by Mikkael Sekeres based on true stories of patients with lukemia. I then had the opportunity to interview Mikkael on my “Outspoken Oncology” Podcast. My book review was originally posted on the HealthCareBlog.
The Health Professional Radio interviewed myself, as well as Dr. Stephen Liu, an oncologist with Medstar Health and an investigator on this study, to discuss the data presentation from the American Society of Clinical Oncology (ASCO 2020) Virtual Scientific Program, Abstract 9544/Poster 310: Characterization of KRAS mutations in non-small cell lung cancer (NSCLC).
I wrote this essay for the HealthCareBlog amid the COVID-19 pandemic. As everyone started discussing re-opening the country and the economy, I reflected back to the 1918 flu pandemic and told the story of the city of Philadelphia. I will always argue that we need to learn from history to determine our present and future.
I wrote this article for the HealthCareBlog amid COVID-19 pandemic. I looked back at the ZIKA story by reading a book that discussed the topic; I attempted to contrast between ZIKA and COVID to identify lessons we should have learned from prior epidemics and pandemics.
I originally wrote this article for the HealthCareBlog amid the COVID-19 pandemic. I was growing tired of how people are using the term “Essential Oncology”, which implies the presence of non-essential oncology. I reflected on the importance to view oncology through the lenses of the most important stakeholders – our patients. COVID-19 is for sure challenging our thinking and behaviors, but we need to always keep patient needs and are front and center in how we proceed.
This is part 2 of an article where was interviewed for at Bio Similar Development. The article was discussing biosimilars and their impact on patients, oncologists, and healthcare system. This is critical as we are experiencing changes in reimbursement models and operational challenges for effective healthcare delivery.
Medscape Oncology Insights recently published an interview I conducted with Dr Jeff Sharman, director of research at Willamette Valley Cancer Institute and medical director of hematology research for The US Oncology Network.
Dr. Nabhan has been podcasting for years. His first podcast “Outspoken Oncology” started in February 2019 and won him two communication awards especially with dedicated coverage to COVID-19 when the pandemic started. That podcast retired in the summer of 2020 and Dr. Nabhan currently hosts two podcasts:
Healthcare Unfiltered: unedited and daring podcast tackling all aspects of healthcare hosting thought leaders from all over the world addressing timely and relevant debates that are important to everyone in the healthcare industry
HemOnc Pulse: Started in December 2022 and is dedicated to hematology and only hematology. Dr. Nabhan hosts thought leaders in the field of hematology discussing recent updates, new published research, debates, and asks questions that are essential to clinical care. This podcast is sponsored by Blood Cancers Today and SOHO.
